Discontinuation report ANANDRON
| Report ID | 228155 |
| Drug Identification Number | 02221861 |
| Brand name | ANANDRON |
| Common or Proper name | Nilutamide |
| Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | NILUTAMIDE |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 90 tablets (3x30) |
| ATC code | L02BB |
| ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2024-05-16 |
| Remaining supply date | 2024-05-16 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-05-17 | English | Compare |
| v3 | 2024-05-16 | French | Compare |
| v2 | 2024-05-16 | English | Compare |
| v1 | 2024-05-16 | English | Compare |
Showing 1 to 4 of 4